Drug companies have been presenting trial data at the American Society of Clinical Oncology...
Sunday, June 3, 2012, 3:17 AM ETDrug companies have been presenting trial data at the American Society of Clinical Oncology meeting in Chicago. Showing good results are J&J's (JNJ) Zytiga for prostate cancer, Roche's (RHHBY.PK) T-DM1 and Avastin for breast and ovarian tumors respectively, Teva's (TEVA) Treanda for the immune system, and Bristol Myers' (BMY) BMS-936558 for lung, kidney and skin cancer.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles